NCT01624766 2021-02-25Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced CancersM.D. Anderson Cancer CenterPhase 1 Completed57 enrolled
NCT04494373 2020-08-04Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy AdultsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 Unknown154 enrolled